News
The Latest Industry News
Insulin Degludec Now FDA-Approved for Type 1 and Type 2 Diabetes
Posted on November 13, 2015On September 25th, the FDA approved Tresiba (insulin degludec / Novo Nordisk), making it the first new basal insulin to be approved in ten years. This is a once-daily, long acting basal insulin. The half-life is 25 hrs and it is active for up to 42 hours. One benefit of Tresiba is that the patient is […]
Read More
“Eat Well, America!”
Posted on November 6, 2015November is American Diabetes Month and this years them is “Eat Well, America!” As the American Diabetes Association® celebrates its 75th anniversary, they want to share a timeless message—that eating well is one of life’s greatest pleasures, and enjoying delicious, healthy food helps with diabetes management. This November, the Association will show our nation how […]
Read More
Endocrine Society Releases New Interactive Guide to the Endocrine System
Posted on November 6, 2015The guide, “Journey Through the Endocrine System”, uses 3-D animation to provide an overview of all endocrine-related organs and their function. A mobile app version will be released in early 2016. The guide is available here: http://www.hormone.org/hormones-and-health/the-endocrine-system.
Read More
Advancements in Insulin Therapy
Posted on October 8, 2015This is an exciting time in Diabetes management as there are several advancements in insulin therapy available now and coming in the near future. These therapies will provide patients with Type 1 and Type 2 diabetes with safer and more effective treatment options moving forward. There are three therapies that we’re discussing here. Toujeo® (Insulin […]
Read MorePOSTS BY TOPIC
